Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L7a pseudogene 54 (RPL7AP54) is a retrocopy of the functional ribosomal protein L7a (RPL7A) gene. Pseudogenes such as RPL7AP54 are non-coding DNA segments originating from functional genes but lacking protein-coding ability due to mutations or incomplete sequences. While most processed pseudogenes have no biological function, some can acquire regulatory capabilities or rare neofunctionalization. RPL7AP54 is considered nonfunctional in humans and shows homology to its parent gene but is not a protein, enzyme, receptor, or direct drug target[1][2][4][5]. RPL7AP54 is a nonfunctional pseudogene and not considered a druggable or therapeutic target. It is important to distinguish this processed pseudogene from its parental gene RPL7A, which is a bona fide member of the ribosomal protein family and is associated with the ribosome’s structural and regulatory functions[3][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L7a pseudogene 54 (RPL7AP54).